ID

22668

Description

CALGB 50901 Response Assessment Form Ofatumumab in Treating Patients With Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma https://clinicaltrials.gov/ct2/show/study/NCT01190449

Link

https://clinicaltrials.gov/ct2/show/study/NCT01190449

Keywords

  1. 4/19/12 4/19/12 -
  2. 6/9/17 6/9/17 - Martin Dugas
Uploaded on

June 9, 2017

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

NHL Ofatumumab NCT01190449 CALGB 50901

Keine Anleitung vorhanden.

  1. StudyEvent: CALGB 50901 Response Assessment Form
    1. Keine Anleitung vorhanden.
Wirkungs-Bewertung
Description

Wirkungs-Bewertung

Alias
UMLS CUI-1
C0521982
UMLS CUI-2
C0220825
Objective-Status bei dieser Evaluierung
Description

Lymphoma Response Type

Data type

text

Alias
NCI Thesaurus ValueDomain
C25284
NCI Thesaurus Property
C25755
NCI Thesaurus ObjectClass
C3208
UMLS CUI [1,1]
C0521982
UMLS CUI [1,2]
C0024299
Datum: Progressive Erkrankung zuerst beobachtet (PD)
Description

First Progression Date

Data type

date

Alias
NCI Thesaurus ObjectClass
C25331
NCI Thesaurus Property
C25509
NCI Thesaurus Property
C25599
NCI Thesaurus ValueDomain
C25164
NCI Thesaurus ValueDomain
C25367
UMLS CUI [1,1]
C0178874
UMLS CUI [1,2]
C0011008
Modifizierter Ann Arbor Stage (Zeitpunkt des Rezidivs mit einem X markieren)
Description

Ann Arbor NHL tumor staging system

Data type

text

Alias
NCI Thesaurus ObjectClass
C3208
NCI Thesaurus ValueDomain
C16899
NCI Thesaurus Property
C25161
UMLS CUI [1]
C0474949

Similar models

Keine Anleitung vorhanden.

  1. StudyEvent: CALGB 50901 Response Assessment Form
    1. Keine Anleitung vorhanden.
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Wirkungs-Bewertung
C0521982 (UMLS CUI-1)
C0220825 (UMLS CUI-2)
Item
Objective-Status bei dieser Evaluierung
text
C25284 (NCI Thesaurus ValueDomain)
C25755 (NCI Thesaurus Property)
C3208 (NCI Thesaurus ObjectClass)
C0521982 (UMLS CUI [1,1])
C0024299 (UMLS CUI [1,2])
Code List
Objective-Status bei dieser Evaluierung
CL Item
 (CR)
C0677874 (UMLS CUI-1)
CL Item
 (PR)
C1521726 (UMLS CUI-1)
CL Item
 (SD)
C0677946 (UMLS CUI-1)
CL Item
 (PD)
C1335499 (UMLS CUI-1)
First Progression Date
Item
Datum: Progressive Erkrankung zuerst beobachtet (PD)
date
C25331 (NCI Thesaurus ObjectClass)
C25509 (NCI Thesaurus Property)
C25599 (NCI Thesaurus Property)
C25164 (NCI Thesaurus ValueDomain)
C25367 (NCI Thesaurus ValueDomain)
C0178874 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Item
Modifizierter Ann Arbor Stage (Zeitpunkt des Rezidivs mit einem X markieren)
text
C3208 (NCI Thesaurus ObjectClass)
C16899 (NCI Thesaurus ValueDomain)
C25161 (NCI Thesaurus Property)
C0474949 (UMLS CUI [1])
Code List
Modifizierter Ann Arbor Stage (Zeitpunkt des Rezidivs mit einem X markieren)
CL Item
I (I)
CL Item
IE (IE)
CL Item
II (II)
CL Item
IIE (IIE)
CL Item
III (III)
CL Item
IIIE (IIIE)
CL Item
IIIS (IIIS)
CL Item
IIIE+S (IIIE+S)
CL Item
IV (IV)

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial